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Summary
The striking morphology of the Golgi complex has fascinated cell biologists since its discovery
over 100 years ago. Yet, despite intense efforts to understand how membrane flow relates to Golgi
form and function, this organelle continues to baffle cell biologists and biochemists alike.
Fundamental questions regarding Golgi function, while hotly debated, remain unresolved. While
Golgi function is historically described from a protein-centric point of view, we now appreciate
that conceptual frameworks for how lipid metabolism is integrated with Golgi biogenesis and
function are essential for a mechanistic understanding of this fascinating organelle. It is from a
lipid-centric perspective that we discuss the larger question of Golgi dynamics and membrane
trafficking. We review the growing body of evidence for how lipid metabolism is integrally
written into the engineering of the Golgi system, and highlight questions for future study.
The Golgi apparatus is a central station for the sorting and transport of protein and lipids that
transit the secretory pathway. This organelle also serves as a biochemical factory where
anterograde cargo is subject to serial post-translational modifications before being sorted at
the trans-Golgi network (TGN) for delivery to the appropriate destinations. As such, the
Golgi system plays a central role in eukaryotic cell biology. At steady-state, Golgi
membranes are typically organized in a stack of flattened cisternae with dilated rims [1].
Such an organization has been argued to reflect the logic for ordering the biochemical
activities of the system. That is, one simply generates stable compartments in the context of
the cisternal arrangement. This steady-state morphology is deceiving, however. The Golgi
complex is a dynamic organelle subject to enormous membrane flux in its capacity as an
intermediate station between the endoplasmic reticulum (ER) and the distal compartments of
the secretory pathway. These fluxes are bidirectional as the Golgi system directs retrograde
trafficking pathways for purposes of retrieval and recycling of Golgi and ER components,
and receives cargo from the PM and endosomes [1].
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The structural plasticity of the Golgi system is evident at multiple levels. In mammalian
cells, this organelle disassembles in mitosis, and subsequently reassembles into a functional
unit upon completion of cell division [2]. Golgi structural plasticity is also on display when
the system is subjected to a variety of perturbations [3]. Disruption of a morphologically
proper Golgi system interferes with the modification, sorting and delivery of proteins, and
with larger cellular processes such as ciliogenesis, cell polarity, cell migration, stress
responses and apoptosis [4–6]. Thus, the forces that shape Golgi morphology exert
unexpectedly broad effects on cell physiology. Perhaps reflective of these larger cellular
functions, individual Golgi stacks are often laterally inter-connected to form a reticular
ribbon positioned in the perinuclear region in proximity to the vertebrate centrosome.
Yet, the Golgi system is resilient. It exhibits remarkable capacities for self-organization
which allow it to recover from catastrophic structural derangements. As example, brefeldin
A-induced collapse of the Golgi system into the ER is followed by re-formation of a
functional organelle upon drug removal [7]. Thus, the steady-state form of the Golgi system
portrays an illusion of compartmental stability. The very existence of the organelle is
balanced on a knife’s edge of competing forces which create it and those that would
consume it. It is the remarkable dynamics of the Golgi system that has, over the past decade,
fueled a re-evaluation of the fundamental nature of this organelle, and maturation concepts
now supplant stable compartment models as favored mechanisms for Golgi biogenesis and
function [8].
Lipid Metabolism and the Golgi System
Initial studies of Golgi membrane trafficking and dynamics were exclusively protein-centric
[9, 10]. It is now appreciated that lipid metabolism is integrally written into the fabric of the
transport carrier cycle and of Golgi function. Since the first demonstrations to this effect in
permeabilized cell systems and in yeast [11–14], we now understand that the interface of
lipid metabolism with membrane trafficking is complex. This interface is a major factor in
controlling Golgi morphology and dynamics. It also involves a large cast of interesting
proteins and enzymes including: lipid transfer proteins [11, 12, 15–18], lipid kinases and
phosphatases [19–22], phospholipases D and A2 [23–25], phospholipid acyl-transferases
[26, 27], and amino-phospholipid flippases which harness their ATPase activities for
topological control of lipid distribution between bilayer leaflets [28–30].
Lipid metabolism interfaces with membrane trafficking in several general ways. First, it
helps create platforms for protein recruitment to, and activation at, appropriate sites on
membrane surfaces. The reduced dimensionality achieved by recruiting soluble factors to a
surface has a powerful concentrating effect that promotes effective biochemistry in systems
governed by modest affinities. In these capacities, lipid metabolism plays signaling roles.
Second, it facilitates the structural deformations of membranes that accompany vesicle
budding, fusion and tubulation. Third, it effects a lateral segregation of molecules, and this
partitioning contributes to Golgi function. For example, regulation by lateral segregation is
the underlying principle of a rapid partitioning model proposed to account for cargo export
kinetics from the Golgi complex [31]. The model is based on a continuous two-phase
system; one that can readily be generated by lipid segregation into fluid and relatively less
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fluid domains. While the continuous two-phase partitioning model is overly simplistic, and
some of its basic tenets are at odds with known properties of the Golgi complex [32], the
concept illustrates how self-organizing principles linked to lipid metabolism/composition
might give rise to complex Golgi functions. Studies suggesting that the trans-membrane
domains of resident proteins are matched to the physical properties of the membranes in
which these reside, also support partitioning concepts [33]. For the remainder of this review,
we organize the discussion from the perspective of classes of lipids and how these molecules
modulate Golgi functions.
PtdIns-4-phosphate and TGN Function
Involvements of phosphatidylinositol (PtdIns), and its phosphorylated derivatives (the
phosphoinositides), were the first established cases for lipids playing active roles in
regulating membrane trafficking [44–48]. PtdIns-4-phosphate (PtdIns-4-P) is an important
phosphoinositide in operation of the Golgi system [34]. That biologically sufficient
production of PtdIns-4-P is integrated with phosphatidylcholine (PtdCho) metabolism
provides a striking demonstration of the cross-talk between lipid metabolism and Golgi
secretory function [11, 12, 35, 36]. The issue of cross-talk is discussed below in the context
of lipid transfer protein function.
Mammalian Golgi membranes harbor two types of PtdIns 4-OH kinases -- PI4KIIIβ and
PI4KIIα. Their respective yeast cognates are Pik1 and Lsb6, and Pik1 is localized to yeast
Golgi membranes [37]. The PI4KIIIβ enzymes are best understood and function as
heterodimers with a myristoylated Ca2+-binding non-catalytic subunit [38, 39]. These PtdIns
4-OH kinases also engage in direct interactions with the vesicle biogenic machinery as
mammalian PI4KIIIβ homes to Golgi membranes by binding the GTP-bound form of Arf1
[40, 41], whereas the yeast ortholog Pik1 targets to Golgi membranes by binding an ARF-
GEF [42].
PtdIns 4-OH kinase catalytic activity is clearly important for Golgi function. Acute
inactivation of yeast Pik1 kinase activity [21, 22], or evoked degradation of PtdIns-4-P to
PtdIns in mammalian Golgi [43], induces trafficking defects. Inactivation of PtdIns-binding
proteins (e.g. Sec14), which potentiate PtdIns 4-OH kinase activities by presenting PtdIns to
the enzyme for efficient modification, also compromises Golgi membrane trafficking [11,
36]. The lipid kinase activity is not the sole essential property of PtdIns 4-OH kinase with
respect to Golgi function, however. The Drosophila PI4KIIIβ binds to a small Rab GTPase
(Rab11) in the TGN and executes a scaffolding function independent of its catalytic activity
[44].
How does PtdIns-4-P potentiate Golgi secretory functions? First, PtdIns-4-P contributes to
the recruitment of peripheral membrane proteins important for transport carrier biogenesis
(Figure 1). These include Golgi adaptors for clathrin binding such as AP-1 [45, 46], and
Arf1-GTP effectors such as GGA proteins [47, 48], Rabs and Rab-GEFs [49, 50], and the
GBF1 Arf-GEF [51]. Oxysterol binding-related proteins interface with PtdIns-4-P signaling
[16–18], and other lipid binding/transfer proteins which further remodel Golgi membrane
lipid composition, are also PtdIns-4-P effectors (see below).
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Second, PtdIns-4-P modulates protein activities by direct binding mechanisms. One example
is the yeast amino-phospholipid flippase Drs2, a Type-IV integral membrane ATPase, which
translocates phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEtn) from the
lumenal- to the cytosolic-leaflets of TGN/endosomal membranes [28–30]. Drs2 flippase
activity is stimulated by binding both to PtdIns-4-P and to an Arf1-GEF [52]. Another
example of PtdIns-4-P binding regulating activity of a protein component of the trafficking
machinery is described by the coincidence-detection mechanism for yeast Sec2 function.
Sec2 is a GEF for the Rab GTPase Sec4. PtdIns-4-P binding quenches the ability of Sec2 to
nucleate assembly of a multi-protein complex (the exocyst) required for the interaction of
secretory vesicles with the plasma membrane [52, 53]. By discouraging premature Sec2-
mediated recruitment of the exocyst to TGN membranes, PtdIns-4-P helps preserve the
compartmental distinction between transport intermediates and the Golgi system.
Recent studies of the yeast PtdIns-binding protein Sec14 and PtdIns-4-P binding protein
Vps74 indicate that retrograde membrane flow from endosomes to the TGN and retention of
glycosyltransferases within the Golgi system is PtdIns-4-P dependent, respectively [54, 55].
PtdIns-4-P binding by Vps74 coordinates the interactions of this protein with the cytosolic
tails of glycosyltransferases and with the coatomer complex [55]. Vps74 is an ortholog of
the mammalian GOLPH3 which collaborates with the nonconventional myosin MYO18A to
control Golgi morphology [55]. In addition, GOLPH3 interacts with the retromer complex
which potentiates retrograde membrane trafficking from endosomes [56]. These data suggest
GOLPH3 also functions in cargo sorting and retrieval in mammals.
The Yin and Yang of Lipid Transfer Proteins and TGN Functions
The extensive lipid involvement in regulating Golgi function demands close coordination of
lipid metabolism with PtdIns-4-P signaling. Lipid transfer proteins are the coupling devices
through which this coordination is executed, and PtdIns-transfer proteins (PITPs) provide
outstanding examples. The major yeast PITP (Sec14) coordinates PtdIns-4-P function in the
trans-Golgi network with the activity of a DAG-consuming pathway for PtdCho
biosynthesis [11–13, 57, 58]. The remarkable structural design for how Sec14 differentially
binds PtdIns and PtdCho is central to how Sec14 is posited to use heterotypic phospholipid
exchange to effect a ‘PtdCho-primed’ PtdIns presentation to PtdIns 4-OH kinases [35, 36].
Such an elaborate presentation mechanism is essential for phosphoinositide homeostasis in
vivo because PtdIns 4-OH kinases are biologically inadequate interfacial enzymes when
asked to modify membrane-incorporated PtdIns – i.e. the presumed natural mode of
presentation. By this view, Sec14-stimulated PtdIns-4-P synthesis is primed in response to
PtdCho metabolic cues [35, 36]. Indeed, mammalian disease mutations forecast such
presentation functions are general properties of Sec14-like proteins [35, 59]. A physical
interaction between Sec14 and PtdIns 4-OH kinases has not been shown, and such an
interaction may not be necessary [15, 16]. Details for how a PtdIns-presentation mechanism
works remain to be elucidated, and other evidence suggests that some mammalian Sec14-
domains involved in vesicle trafficking bind both lipids and proteins [60].
The pro-secretory activities of yeast Sec14 are opposed by Kes1 (Osh4) -- a member of an
unrelated class of lipid transfer proteins (the oxysterol binding related proteins -- ORPs) [15,
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16]. Kes1 binds PtdIns-4-P, this activity is essential for Kes1 biological activity as a
trafficking ‘brake’ [15, 16], and the Kes1/Sec14 antagonism plays itself out in the context of
PtdIns-4-P signaling [16, 18, 61]. How this occurs is not clear. Some evidence suggests
ORPs stimulate phosphoinositide phosphatases that degrade PtdIns-4-P [e.g. Sac1, see
below; [18]. Other data indicate Kes1 competes with pro-secretory factors for PtdIns-4-P
binding [62]. Kes1 exhibits two PtdIns-4-P binding sites – one on the protein surface [16],
and the second involves the hydrophobic cavity and overlaps the sterol binding site [63].
PtdIns-4-P binding is essential for Kes1 localization to TGN/endosomal membranes.
Missense substitutions in either PtdIns-4-P binding site render Kes1 incompetent for
targeting to TGN/endosomes [16, 62].
With regard to sterol binding, it is now clear that sterol-binding defects enhance Kes1
biological activity as TGN/endosomal trafficking ‘brake’ [62, 64]. These findings are in
direct contradiction to a prominent claim that sterol-binding is required for Kes1 function in
vivo [65]. The dual PtdIns-4-P/sterol-binding activities of Kes1 cooperate in a rheostat
mechanism where the interplay between sterol- and PtdIns-4-P binding controls the
amplitude of the Kes1-imposed PtdIns-4-P clamp on TGN/endosomal trafficking [62]
(Figure 2). The discovery that the Kes1 sterol-binding site overlaps with a PtdIns-4-P
binding site neatly accounts for how sterol tunes Kes1-mediated inhibition of PtdIns-4-P
signaling. When coupled with the demonstration that Kes1 and other ORPs are collectively
dispensable for non-vesicular sterol transfer in yeast [66], the data indicate Kes1 is not a
sterol transfer protein in vivo; as has been argued [67, 68].
The Kes1 rheostat has larger physiological involvements as it sets the gain of endosomal
sphingolipid signaling, modulates TOR activation by amino acids, regulates nuclear activity
of the major transcriptional activator of the general amino acid control pathway, and
administrates a coherent exit from proliferative programs to quiescent states (Figure 2). The
transcriptional arm of this novel endosome/nuclear axis involves the cyclin-dependent
kinase module of the ‘large Mediator’ complex [62]. Whether mammalian PITPs and ORPs
play similarly opposing functions is a question for future inquiry. The idea that a PITP/ORP
‘tug-of war’ fine-tunes cell growth regulation and metabolic control as a function of TGN/
endosomal trafficking flux has interesting implications for cell entry into post-mitotic fates,
and for tissue biogenesis [62].
Metazoan Lipid Transfer Proteins and the Golgi System
The Steroidogenic Acute Regulatory Protein-related Lipid Transfer (StART)-like
mammalian PITPs are structurally unrelated to Sec14-like PITPs, and functional depletion
of specific isoforms (i.e. PITPβ) is reported to compromise COP1-mediated retrograde Golgi
to ER transport [69]. This defect purportedly comes without compromise of anterograde ER
to Golgi trafficking -- a curious result given retrograde transport is essential for recycling of
v-SNARES for anterograde ER to Golgi transport. With regard to vertebrate PITPβ,
zebrafish with strongly reduced PITPβ levels develop normally, although these exhibit
defects in outer segment biogenesis and/or maintenance in double cone photoreceptor cells
[70]. These data argue against housekeeping roles for PITPβ in retrograde Golgi to ER
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trafficking, although such functions might be important in specialized contexts that require
high-capacity membrane flux.
Other StART-like PITPs are reported to play roles similar to yeast Sec14 in coordinating
Golgi PtdCho and DAG metabolism with PtdIns-4-P signaling [17]. Nir2 is a multi-domain
PITP reported to collaborate with two other StART-domain lipid transfer proteins, an
oxysterol binding protein (OSBP) and a ceramide transfer protein (CERT), in forming a
membrane contact site (MCS). The MCS is hypothesized to bridge TGN and ER membranes
– a concept that couples TGN activities with those of the ER [71]. For purposes of
discussion, the hypothetical MCS is illustrated in Figure 3. Both OSBP and CERT are
PtdIns-4-P binding proteins and both are PKD substrates [72]. In this model, CERT supplies
the TGN with ceramide via a mechanism where PtdIns-4-P binding mediates CERT
interaction with TGN membranes, and CERT phosphorylation by PKD releases CERT from
the TGN [73] (Figure 3). Current models propose CERT fuels sphingomyelin synthase-
driven DAG production in the Golgi at the expense of ceramide. DAG recruits PKD which
then activates PI4KIIIβ [71]. Nir2, a large protein for which the PITP domain accounts for
ca. 20% of the polypeptide, is posited to co-assemble into the CERT/OSBP MCS for the
purpose of transferring PtdIns from the ER to the Golgi to sustain PI4KIIIβ activity [71]. In
sum, this specific MCS model assigns essential roles for CERT, Nir2 and OSBPs in
promoting membrane trafficking from the Golgi complex [74].
CERT and Nir2 gene ablation data fail to support the basic hypotheses, however. CERT-less
Drosophila develop normally and reach adulthood. Although cert0/0 flies age prematurely
due to oxidative plasma membrane damage, these animals are otherwise remarkably
unaffected [75]. By contrast, cert0/0 mice expire at embryonic day 11.5 from failure in
cardiac organogenesis. However, cert0/0 embryonic fibroblasts are viable, and these too are
prone to accelerated senescence [76]. Thus, the evidence consistently highlights CERT
involvements in oxidative stress management. While CERT requirements in trafficking of
unusual cargos required for organogenesis remain formal possibilities, genetic data argue
against CERT involvements in core Golgi trafficking functions. It is also yet to be
demonstrated that CERT bridges ER and Golgi membranes in vivo. This is a critical tenet of
the MCS model (Figure 3).
Are Nir2-like PITPs obligatorily required for function of metazoan Golgi -- as proposed
[71]? Available evidence does not support this hypothesis either. Drosophila mutants
ablated for their single Nir2 ortholog (RdgB) survive through adulthood. Nir2-less flies do
suffer a rapid light-accelerated retinal degeneration caused by inability of photoreceptors to
terminate the photo-response. This degeneration is cured by expression of the isolated RdgB
PITP domain which presumably does not efficiently assemble into an MCS, and the rescue
comes with a restored photo-response – even under saturating light conditions [77]. This is
an impressive outcome given the enormous phosphoinositide flux demanded by this
signaling cascade. Mammals employ Nir2 differently than do flies, however, as evidenced
by the demonstration that nir20/0 mice suffer pre-implantation lethality [78]. The terminal
nir20/0 phenotype in mice is uncharacterized so it is unknown whether lethality stems from
Golgi trafficking defects, or not. There is also no direct evidence to indicate Nir2 functions
in a PtdIns-supply capacity – even though this is the common interpretation. Whether
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StART-like PITPs operate in cells as PtdIns-presenting scaffolds, or as PtdIns carriers, is
difficult to determine in vertebrate systems. These two modes of action differ in
fundamental respects and are discussed from alternative points of view [71, 79]. However,
vertebrate StART-like PITPs resemble their yeast and plant Sec14-like PITP counterparts in
having the intrinsic capacity to potentiate PtdIns 4-OH kinase activities under conditions
where PtdIns supply requirements are moot [70]. Moreover, the discovery that PtdIns-
synthase mobilizes from ER to sites adjacent to plasma membrane and other organelles, to
replenish phosphoinositide signaling pools in those membranes, challenges the fundamental
assumption for why cells would even require bona fide PtdIns-transfer proteins [80].
Sac1 Phosphoinositide Phosphatases and the Golgi System
Maintenance of phosphoinositide homeostasis requires balanced control over the
biosynthetic and the degradative aspects of their metabolism. Phosphoinositide turnover is
the domain of lipid phosphatases (e.g. synaptojanins, the oculocerebrorenal Lowe’s
Syndrome OCRL protein, PTEN, myotubularins, etc). These enzymes are particularly
interesting because of their association with a variety of diseases [81–84]. The mixed
specificity phosphoinositide phosphatase Sac1 localizes to ER and Golgi membranes, and is
unique amongst the inositol lipid phosphatases in that it is an integral membrane protein [19,
85]. This enzyme is incapable of utilizing phosphoinositides with vicinal phosphate groups
as substrates [20]. Sac1 executes larger roles in cell physiology on the basis of its
modulation of PtdIns-4-P signaling in both yeast and mammals. Under conditions of
extreme nutrient or growth factor insufficiency, the Sac1 PtdIns-4-P phosphatase
redistributes from the ER to the Golgi complex [86]. Presumably, regulated trafficking of
the phosphatase discourages cell proliferation by clamping activity of the distal secretory
pathway (via degradation of Golgi PtdIns-4-P) under suboptimal growth conditions.
Sac1 dysfunction also alleviates the normally essential requirement for PtdIns-transfer
protein activity for Golgi secretory function in yeast [19, 85]. This outcome reflects Sac1
constituting the major activity for PtdIns-4-P degradation in yeast [20, 58]. Paradoxically,
this enzyme specifically consumes the PtdIns-4-P produced by the plasma membrane-
localized Stt4 PtdIns 4-OH kinase, and not the Golgi-localized Pik, in yeast [87, 88]. It is
unknown whether this pool specificity translates to mammals. While Sac1-insufficiencies do
not evoke large derangements in bulk PtdIns-4-P mass in mammalian cells, these do result in
pre-implantation lethality, morphological derangements of the Golgi, defects in mitotic
spindle organization, mis-sorting of Golgi glycosyltransferases, and aberrant protein
glycosylation [89, 90].
Diacylglycerol and the Transport Carrier Cycle
In addition to PtdIns-4-P, to which we assign primarily a signaling role, a number of other
lipids also have key involvements in Golgi functions. Some of these lipids likely play both
signaling and structural roles. Diacylglycerol (DAG), a neutral lipid with unusual physical
properties, is one of these. The extreme inverted cone shapes assumed by DAG (due to its
small headgroup to acyl chain axial area ratio) facilitate adoption of the non-bilayer
configurations that lipid molecules assume in strongly deformed membrane regions. Such
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deformations accompany both vesicle budding and scission [91, 92]. Accordingly, DAG
regulates vesicle budding at multiple steps in the exocytic pathway. These include transport
from the yeast and mammalian TGN [17, 57, 93–95], and formation of mammalian COP1-
vesicles for retrograde trafficking from early Golgi cisternae to the ER [65,66].
In some cases, DAG directly regulates the activity of protein components of the trafficking
machinery. For example, DAG potentiates Arf-GTPase activating protein (Arf-GAP)
function in both yeast and mammals [93, 95], and DAG exhibits at least two execution
points in mammalian COP1-dependent vesicle biogenesis. One is at an early step in
formation of buds/tubules when the membrane is first deformed, and another at the scission
step where the nascent vesicle is released from its donor membrane [96, 97] (Figure 1).
DAG involvement in scission requires ArfGAP1 activity -- suggesting DAG potentiates
scission both by activating ArfGAP1 and by facilitating formation of non-bilayer membrane
structures which characterize fission intermediates [96]. DAG-activated PKD also displays
vesicle scission execution points in the TGN [98, 99]. Although there is as yet no evidence
for obligate DAG involvements in early stages of the yeast secretory pathway, roles for
DAG in yeast TGN are documented [96].
Compartment-specific requirements imply DAG primarily functions in a signaling capacity.
In that regard, DAG recruits protein kinase D (PKD) isoforms to mammalian TGN
membranes [94]. PKD activation serves as the nexus of a larger signaling hub which
connects DAG metabolism to downstream lipid metabolic events required for optimal
membrane trafficking from the TGN [98–100] (Figure 1). This larger hub includes the
recruitment of PI4KIIIβ -- which generates PtdIns-4-P in the TGN with the pro-trafficking
sequelae detailed above. DAG recruits protein kinases C, Ras guanosine nucleotide release
proteins [101–104], and PKCή (which phosphorylates PKD and activates the enzyme) to
TGN membranes as well [105].
Phosphatidic Acid Metabolism and Golgi Membrane Trafficking
Pools of DAG generated from phosphatidic acid (PtdOH) by the action of PtdOH
phosphatases are required for membrane trafficking through yeast and mammalian Golgi
[96, 97]. That PtdOH itself executes pro-secretory functions was suggested by
demonstrations that phospholipase D (PLD), an enzyme which hydrolyzes PtdCho to PtdOH
and choline, is activated by PtdIns(4,5)P2 and Arf-GTP [23, 25]. Mammals express two
PLD isoforms – PLD1 and PLD2 – and numerous studies claim obligatory PLD1 and/or
PLD2 involvements in producing PtdOH pools essential for membrane trafficking through
the mammalian Golgi system [106, 107]. Biochemical studies suggest PtdOH acts in concert
with its binding proteins endophilin and BARS in scission of COP1 vesicles whose
formation is Arf-GTP-dependent [108, 109] (Figure 1). In vitro studies suggest endophilin
and BARS resolve fission intermediates by physically deforming membranes, and that a
PtdOH pool generated by PLD2 is required for execution of these functions [110]. In vivo
relevance is suggested by siRNA experiments that show PLD2 is necessary for cis-Golgi
maintenance, and for KDEL-receptor retrieval from early Golgi cisternae back to the ER
[111]. DAG kinases (enzymes which produce PtdOH from DAG) fail as PLD2 surrogates in
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this system [111], suggesting direct roles for PLD-generated PtdOH pools in Golgi function.
Whether PtdOH serves as a DAG precursor in these contexts is unresolved.
PtdOH Remodeling Enzymes and Golgi Dynamics
Phospholipids are subject to two-stage remodeling reactions that convert one molecular
species of a particular phospholipid to another. The first reaction involves removal of the
sn-2 fatty acid from the glycerol backbone of a phospholipid by a phospholipase A2 to form
a lyso-phospholipid with a single acyl chain. The lyso-phospholipid is a substrate for
acyltransferases that incorporate another fatty acid at sn-2 to regenerate the original
phospholipid, albeit a different molecular species. That PtdOH remodeling enzymes
contribute to Golgi dynamics and trafficking was suggested by reports that endophilin and
BARS are lyso-PtdOH acyltransferases [108, 109]. More detailed analyses showed these
proteins have no such activity, however [112]. The evidence indicates a phospholipase A2/
lysoPtdOH acyltransferase (LPAAT) cycle regulates tubulation events which potentiate
membrane trafficking and cargo sorting in mammalian Golgi [24, 26, 27, 113].
Phospholipase A2-induced Golgi tubulations are enhanced by secretory cargo, and these
tubules consolidate what would otherwise be individual Golgi stacks into a Golgi ribbon
[24, 26, 27, 113]. Connecting tubules are suggested to represent the portals through which
anterograde cargo passes as it transits from one Golgi cisterna to the next.
COP1/BARS initiate formation of both tubules and vesicles from mammalian Golgi
membranes in vitro [114]. Growing tubules are stabilized by cytosolic phospholipase A2
(cPLA2-α) activity on the one hand, and resolved into vesicles by LPAAT-γ on the other. In
these assays, tubules score as non-concentrative cargo carriers, while vesicles score as
concentrative carriers -- suggesting that anterograde trafficking is a passive process while
retrograde trafficking is an active one [114]. Because formation of both tubules and vesicles
is COP1-dependent, this idea offers a resolution to the debate of whether COP1-coated
membranes define anterograde- or retrograde-carriers by conceptualizing how COP1 might
participate in both pathways [32]. How general cPLA2/LPAAT mechanisms are as a core
Golgi trafficking strategy is unclear given yeast and worms do not produce obvious
LPAATs. However, yeast exhibit a naturally vesiculated Golgi – a feature that might obviate
an LPAAT requirement. Also, some organisms might employ monoacylglycerol-
acyltransferases, rather than LPAATs, for vesicle scission.
Genetic Models for Phospholipase D Function
Given the pharmacological and biochemical evidence for PLD-generated PtdOH pools in
driving multiple aspects of membrane trafficking, it is surprising that mice nullizygous for
either the PLD1 or PLD2 structural genes are developmentally normal [115, 116]. The
PLD1 null model does reveal a PLD1 requirement in both starvation-induced expansion of
autophagosomes, and for clearance of protein aggregates in brain tissue by macro-autophagy
[96]. The enzyme relocalizes from endosomes to the outer membrane of autophagosomes in
the face of nutrient stress via a mechanism that requires PtdIns 3-OH kinase activity [96].
PLD2-nullizygous mice, while also overtly normal, present enhanced resistance to the
neurotoxic effects of amyloid β-peptide [96]. Perhaps most surprising is that PLD1 and
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PLD2 activities fail to cross-compensate to any significant degree as pld10/0 pld20/0 double
mutant mice do not appear to exhibit enhanced phenotypes relative to the respective single
mutants (Gilbert DiPaolo; personal communication).
Does DAG-kinase-mediated conversion of DAG to PtdOH compensate for PLD in
nullizygous mice and cells? While an unresolved question, compensation by DAG-kinases
would necessarily operate in the absence of the numerous physical interactions reported for
PLD isoforms with membrane trafficking components and proteins involved in lipid
signaling [96]. Such functional compensation would also be inconsistent with conclusions of
in vitro experiments that contend PtdOH pools produced by DAG-kinases cannot substitute
for those generated by PLD2 – at least not for COP1 vesicle budding [111]. Why the
dissonance? In vitro reconstitutions, their power notwithstanding, are inefficient systems.
Consequently, these might exhibit non-physiological dependences on particular lipid
metabolic pathways for basic operation (i.e. those that preserve a relative robustness in cell-
free preparations) – even when the in vitro system faithfully reconstitutes a specific lipid
requirement.
The non-essentiality of PLD for core trafficking functions is also the case in fungi as the
single PtdCho-specific yeast PLD is dispensable in vegetative cells [117]. PLD catalytic
activity is required for membrane trafficking in certain lipid transfer protein-deficient
mutants, however [118]. A physiological role for PLD is on display in the developmental
reorientation of membrane trafficking from the TGN to the nuclear envelope during
sporulation. PLD produces a PtdOH pool which recruits and activates a sporulation-specific
t-SNARE of the Sec9/SNAP-25 family (Spo20). This t-SNARE re-directs post-Golgi
trafficking to the forming nuclear envelopes at the expense of the plasma membrane, and
PLD defects prevent post-Golgi vesicle fusion with nascent nuclear envelopes [119]. Thus,
PtdOH generated by PLD landmarks a developmentally-regulated vesicle fusion process --
not vesicle formation or vesicle scission.
Genetic Models for BARS Function
How congruent are in vivo models with in vitro data for endophilin and BARS function as
PtdOH effectors in membrane trafficking? In the case of endophilin there is good agreement
as this protein is indeed essential for fission and uncoating of clathrin-coated vesicles in
neurons [120–122]. BARS is reported to be essential for fragmentation of the Golgi ribbon
in cultured cells, and ribbon scission is required for cells to negotiate the G2/M boundary.
Interestingly, only cells with Golgi ribbons exhibit BARS-regulated Golgi mitotic
checkpoints [123]. These findings emphasize the link between Golgi structure, lipid
metabolism, and cell cycle control.
BARS has a curious history, however, as it was first described as a member of the CtBP
protein family of transcriptional co-repressors, and is a spliceoform of CtBP1 [124]. BARS/
CtBP null (ctbp10/0) mice exhibit various developmental phenotypes associated with defects
in body size, vascularization and body patterning. These phenotypes primarily reflect the
transcriptional functions of BARS. The ctbp10/0 phenotypes, and the viability of ctbp10/0
embryonic fibroblasts, are neither consistent with essential roles for BARS in Golgi
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housekeeping functions, nor with obligate requirements for BARS in progression through
the G2/M Golgi checkpoint [124]. It is noted that the Golgi system of ctbp10/0 embryonic
fibroblasts differs from that of wild-type fibroblasts in that it is not organized as an intact
ribbon, and this morphological derangement is argued to relieve ctbp10/0 fibroblasts of a
BARS requirement for cell cycle progression [123]. This argument begs the question of how
is fragmentation of the Golgi ribbon realized in BARS-less cells? What activity (if any)
compensates for BARS in ctbp10/0 cells? Non-neuronal endophilins are candidates, and in
vitro data support this notion [125]. But, given the dissonance between in vitro and in vivo
readouts, this hypothesis must be tested in a suitable in vivo context.
Amino-phospholipids and Membrane Trafficking
Functional involvements of glycerophospholipids in Golgi secretory function are not limited
to PtdIns, phosphonositides, PtdCho, and PtdOH. Roles for amino-phospholipids, such as
PtdEtn and PtdSer, in membrane trafficking is amply demonstrated by the important roles
amino-phospholipid-flippases (i.e. Drs2) play in controlling membrane trafficking through
the yeast TGN/endosomal system [28–30]. These P4-type ATPases translocate PtdSer and
PtdEtn from cytosolic- to lumenal- membrane leaflets, and these activities interface with
PtdIns-4-P signaling and the Arf pathway as yeast Drs2 flippase activity is stimulated by
binding both to PtdIns-4-P and to an Arf1-GEF [52]. Yeast P4-type ATPases are also
indirectly subject to regulation by sphingolipids via the Fpk protein kinases that
phosphorylate (and activate) the flippases [126].
The complexity of the amino-phospholipid flippase involvement in yeast membrane
trafficking is emphasized by the overlapping functional redundancies of multiple Drs2-like
flippases [28–30]. A long-standing idea is that amino-phospholipid flippases promote
positive membrane curvature (and therefore vesicle budding) by driving local leaflet
asymmetries -- both in terms of phospholipid composition and phospholipid distribution
between the cytosolic and lumenal TGN/endosomal leaflets [28–30]. While the evidence
identifies an interface of Drs2 (and Drs2-like flippases) with Arf and clathrin-dependent
functions in yeast [34], it remains to be determined how flippase activities potentiate
membrane trafficking. Is removal of PtdEtn/PtdSer from the cytosolic leaflet of functional
import? Is enrichment of the lumenal leaflet with PtdEtn/PtdSer the key? Are both outcomes
functionally significant?
Trafficking functions for PtdSer disposed on the cytosolic-leaflets of endosomal membranes
are also recognized. This amino-phospholipid is required for retrograde membrane
trafficking from mammalian recycling endosomes [127]. The primary, and perhaps
exclusive, PtdSer effector in this system is evectin-2. This protein harbors a pleckstrin
homology (PH) domain that displays an exquisite specificity for PtdSer, and does not bind
phosphoinositides. PtdSer binding is required for evectin-2 localization to recycling
endosomes and for protein function in cells [127]. How evectin-2 regulates trafficking
remains to be elucidated.
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Sterols and the Golgi Complex
Membrane sterol content increases progressively through the compartments of the secretory
pathway, and this gradient facilitates membrane protein sorting [128]. Sterols organize
plasma membrane microdomains that modulate endocytosis and receptor activation and
regulate membrane trafficking from the TGN. Biosynthetic trafficking of a subset of yeast
plasma membrane proteins is disrupted by defects in sterol biosynthesis [129–131]. A
common property of the affected cargos is their incorporation into ergosterol-containing
detergent resistant membranes [132]. Interestingly, compromise of late steps in sterol
biosynthesis results in missorting of these cargos– even though bulk sterol levels are
unchanged under those conditions. The chemical profile of the accumulated sterols is
altered, however [133]. These accumulated sterols, while chemically distinct from
ergosterol, support formation of detergent resistant membrane microdomains. Yet, integral
membrane proteins destined for the plasma membrane are missorted; indicating subtle
differences in sterol structure influence trafficking fidelity.
Budding of anterograde vesicles from the TGN is proposed to be driven by the phase
separation of sterol and sphingolipids into microdomains where the immiscibility of two
liquid phases in lipid bilayers promotes the membrane bending necessary for this process
[134]. Indeed, sterols and sphingolipids are enriched in TGN-derived vesicles relative to the
bulk composition of the donor organelle [132, 135]. The data suggest that a single lipid-
driven sorting process drives biogenesis of TGN-derived vesicles bound for the plasma
membrane [132]. This mechanism diverges from that which governs COP1 vesicle budding
from bulk Golgi membranes in vitro. Those vesicles exhibit reduced sphingomyelin and
cholesterol content relative to the bulk Golgi membranes from which these were formed
[136]. Yet, sphingomyelin discharges an important role as cofactor in COP1 vesicle
formation. Brügger, Wieland and colleagues report the remarkable discovery that a single
molecule of a specific sphingomyelin molecular species binds the transmembrane domain of
a COP1 coat subunit (p24), modulates the oligomeric state of p24, and thereby regulates
COP1 coat biogenesis [137].
Glycolipid Transfer Proteins
Glycolipid transfer proteins (GLTPs) bind both sphingoid- and glycerol-based glycolipids
and mobilize these lipids between membrane bilayers in vitro [138]. The glucosylceramide
(GlcCer) transfer protein FAPP2 is recruited to Golgi membranes in a PtdIns-4-P-dependent
manner, and is required for production of complex glycosphingolipids for which GlcCer is a
precursor. Although FAPP2 is suggested to deliver GlcCer to distal Golgi compartments as a
lipid carrier [139], others report FAPP2 promotes retrograde transport of GlcCer from Golgi
to the ER [140]. The rationale for the retrograde pathway is that newly synthesized GlcCer,
which resides in the cytosolic leaflet of Golgi membranes, is mobilized to ER for the
purpose of being flipped into the lumenal ER leaflet (Figure 3). Vesicular trafficking from
ER to the Golgi subsequently introduces the lumenally-disposed GlcCer to Golgi-localized
glycosyltransferases for maturation into complex glycosphingolipids [140]. A GlcCer-
independent role for FAPP2 in TGN trafficking is suggested by FAPP2 forming a curved
dimer that tubulates membranes in a PtdIns-4-P-dependent manner [141]. These studies
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describe a mechanism for how FAPP2 potentiates cargo transport from the TGN to apical
surfaces of polarized epithelial cells [142].
Concluding Thoughts
Much progress has been made in understanding the mechanisms that control Golgi dynamics
and architecture since discovery of this organelle more than 100 years ago. Lipids, lipid-
binding proteins, and lipid metabolism are major contributors to plasticity of the Golgi
system. However, we have only a rudimentary understanding of the cross-talk between
different arms of the Golgi lipid metabolome. ‘Systems’ approaches to model the landscape
of Golgi lipid metabolism will be necessary for detailed description of cross-talk
mechanisms. These ‘systems’ approaches also hold the ultimate promise of unifying lipid
biochemical principles with function of the organelle.
It still remains unclear why the Golgi adopts its characteristic morphology given secretory
activity can be insensitive to dramatic structural derangements of this organelle. The answer
must lie in unappreciated levels of physiological regulation associated with how the Golgi is
organized, or with the maturation process itself. Insights to this effect are offered by tunable
PITP/ORP rheostats as these suggest mechanisms for integrating TGN/endosomal
maturation (and lipid signaling) with control of cell proliferation and nuclear responses to
stress [62]. These circuits speak to an unappreciated physiological plasticity of Golgi/
endosomal maturation programs, and involvements of such rheostats in modulating Golgi
plasticity. Such circuits seem ideally suited for chaperoning cell entry into post-mitotic
states, or in maintaining post-mitotic cell physiology. Perhaps maturation mechanisms for
membrane trafficking evolved, in part, because these afford superior instruments for fine-
tuning of cell growth regulation and metabolic control than do stable compartment
mechanisms. In this regard, the fidelity of mitotic spindle formation and function is also
influenced by Golgi organization, and evidence is building that lipid metabolism has its
hand in this circuit as well [92,98,141,142]. We anticipate that studies of Golgi lipid
metabolism, in the developmental context of multicellular organisms, will prove a major
contributor to the future of Golgi research. The fruits of those studies will undoubtedly yield
more surprises from an organelle that has already produced its share.
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Figure 1. Lipid metabolism and formation of transport carriers
This diagram highlights existing views of the interface between lipid metabolism and
components of the protein machinery which drives formation of vesicles or tubular transport
carriers in mammals. No obvious CERT- or PKD activities are present in yeast, and yeast do
not exhibit obvious counterparts for BARS, endophilin or LPAATs. The dissonance between
this diagram and in vivo readouts for PLD, BARS and CERT function in mammals is
discussed in the text. Abbreviations: Cer, ceramide; LPC, lyso-PtdCho; PAP, PtdOH
phosphatase; SM, sphingomyelin; SMS, sphingomyelin synthase.
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Figure 2. Kes1 integrates PtdIns-4-P signaling, sterols, TGN trafficking control, and larger
cellular physiological responses
Kes1 is recruited to Golgi membranes by virtue of its ability to bind PtdIns-4-P where it
clamps availability of this phosphoinositide and functions as a trafficking ‘brake’ [62].
Sterol binding at the TGN releases Kes1 from the membrane, thereby releasing the
trafficking brake. Larger consequences of this negative regulation of membrane trafficking
include TGN/endosomal sphingolipid metabolism-mediated control of cell proliferation,
TOR signaling, and execution of nitrogen stress transcriptional responses.
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Figure 3. Lipid transfer proteins and a hypothetical membrane contact site
CERT, OSBP and Nir2 are proposed to co-assemble into a TGN/ER membrane contact site
(MCS) where these proteins catalyze ER to TGN trafficking of ceramide, sterol and
PtdIns-4-P, respectively. CERT and OSBP interact with the TGN by virtue of their PtdIns-4-
P-binding activities. Nir2 is proposed to supply the TGN with PtdIns from the ER for
sustained PtdIns-4-P production. The MCS is envisioned to be held together by integral
membrane proteins of the ER (the VAPs) which bind the FFAT motifs of CERT, OSBP and
Nir2, and the lipid transfer activities are proposed to be essential for membrane trafficking
from the Golgi complex. The concepts highlighted by asterisks are not supported by
available in vivo data (see text).
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